The venture capital arms of CVS Health, Cigna, Humana and Houston-based Memorial Hermann participated in a $375 million funding round for Monogram Health, an in-home healthcare company specializing in providing care and benefit management services to patients with polychronic conditions.
Monogram plans to use the capital to expand its kidney care and clinical technology. With the new financing, Monogram’s investor base serves over 30 percent of Medicare Advantage members, according to a Jan. 9 Monogram news release.
The company was founded with a focus kidney care.
